Group-II metabotropic glutamate receptors negatively modulate NMDA transmission at striatal cholinergic terminals: Role of P/Q-type high voltage activated Ca++ channels and endogenous dopamine-Reference-Cited by-同舟云学术

Group-II metabotropic glutamate receptors negatively modulate NMDA transmission at striatal cholinergic terminals: Role of P/Q-type high voltage activated Ca++ channels and endogenous dopamine

Published:2006-02 Issue:2 Volume:31 Page:284-292
ISSN:1044-7431
Container-title:Molecular and Cellular Neuroscience
language:en
Short-container-title:Molecular and Cellular Neuroscience

Author:

Mela Flora,Marti Matteo,Fiorentini Chiara,Missale Cristina,Morari Michele

Publisher

Elsevier BV

Subject

Cell Biology,Cellular and Molecular Neuroscience,Molecular Biology

Reference51 articles.

1. Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-d-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro;Ambrosini;Mol. Pharmacol.,1995

2. Effect of the nigrostriatal dopamine system on acquired neural responses in the striatum of behaving monkeys;Aosaki;Science,1994

3. Control by GABA and tachykinins of the evoked release of acetylcholine in striatal compartments under different modalities of NMDA receptor stimulation;Blanchet;Brain Res.,2000

4. Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease;Calabresi;Exp. Neurol.,1999

5. Regulation of neurotransmitter release by metabotropic glutamate receptors;Cartmell;J. Neurochem.,2000

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Presynaptic release‐regulating NMDA receptors in isolated nerve terminals: A narrative review;British Journal of Pharmacology;2021-02-02

2. Presynaptic Release-regulating Metabotropic Glutamate Receptors: An Update;Current Neuropharmacology;2020-07-28

3. Selective basal ganglia vulnerability to energy deprivation: Experimental and clinical evidences;Progress in Neurobiology;2018-10

4. In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu 2/3 receptor antagonist;Neuropharmacology;2017-03

5. mGlu2 Receptor Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards Their Primary Efficacy on Sleep Measures in Rats;PLOS ONE;2015-12-11